Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cells From Human Exfoliated Teeth for Diabetes
NCT03912480Phase 1Unknown
- Sponsor
- CARsgen Therapeutics
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Stem Cells From Human Exfoliated Teeth in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM), sponsored by CARsgen Therapeutics. Primary endpoints: Total daily insulin dose at 12 months and Glucose-C peptide release test at 12 months. Status: unknown.
02
Drugs
Stem Cells From Human Exfoliated Teeth
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03912480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03912480.